A prostaglandin analog with selectivity to EP receptors and demonstrating
EP agonist activity that may be used to expand hematopoietic stem cell
populations or to treat or prevent influenza, bone fracture, bone
disease, glaucoma, ocular hypertension, dysmenorrhoea, pre-term labor,
immune disorders, osteoporosis, asthma, allergy, male sexual dysfunction,
female sexual dysfunction, periodontal disease, gastric ulcer, renal
disease, or other EP receptor-mediated conditions.